- Home
- / Apeloa Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Apeloa Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥16.6
2024-10-29
Market Capitalization
¥18.9 B
2024-10-29
Revenue
¥9.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.3B | 7.2B | 7.8B | 8.9B | 10.5B | 11.4B | 11.9B | 9.7B |
| Cost of goods sold | 4.3B | 4.9B | 5.7B | 6.6B | 8.0B | 8.5B | 9.2B | 7.2B |
| Gross profit | 2.0B | 2.3B | 2.2B | 2.3B | 2.5B | 2.9B | 2.8B | 2.5B |
| Gross profit margin, % | 32.0% | 27.7% | 26.4% | 23.8% | 25.4% | 23.6% | 26.0% | |
| Operating expense total | 1.2B | 1.3B | 1.0B | 1.0B | 1.1B | 1.2B | 1.2B | 905.2M |
| Depreciation and amortization | 353.5M | 362.7M | 343.8M | 355.1M | 376.6M | 540.0M | 564.2M | 664.4M |
| EBITDA | 803.5M | 989.9M | 1.2B | 1.3B | 1.3B | 1.7B | 1.6B | 1.6B |
| EBITDA margin, % | 13.8% | 15.4% | 15.1% | 12.9% | 14.7% | 13.5% | 16.5% | |
| EBIT | 451.2M | 667.3M | 965.7M | 1.0B | 966.1M | 1.1B | 1.1B | 987.7M |
| EBIT margin, % | 9.3% | 12.4% | 11.4% | 9.2% | 9.9% | 9.3% | 10.2% | |
| Interest income | 5.4M | 7.3M | 24.9M | 75.3M | 75.8M | 113.5M | 92.2M | 112.0M |
| Interest expense | 42.0M | 30.2M | 5.2M | 15.7M | 29.2M | 34.2M | 28.6M | 23.8M |
| Pre tax profit | 462.2M | 633.7M | 961.2M | 1.1B | 1.0B | 1.2B | 1.2B | 1.1B |
| Income tax expense | 91.6M | 80.3M | 144.4M | 158.5M | 22.9M | 149.3M | 172.4M | 175.5M |
| Net Income | 370.6M | 553.4M | 816.7M | 955.6M | 989.2M | 1.1B | 1.0B | 890.7M |